Perspectives and experiences of Dutch multiple sclerosis patients and multiple sclerosis-specialized neurologists on injectable disease-modifying treatment

BACKGROUND: The adherence to treatment with injectable disease-modifying drugs (DMDs) in multiple sclerosis (MS) may benefit from adequate information provision and management of expectations. The communication between patients and physicians is very important in this respect. The current study inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Visser, Leo H, Heerings, Marco A, Jongen, Peter J, van der Hiele, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854242/
https://www.ncbi.nlm.nih.gov/pubmed/27175066
http://dx.doi.org/10.2147/PPA.S106155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854242/
https://www.ncbi.nlm.nih.gov/pubmed/27175066
http://dx.doi.org/10.2147/PPA.S106155

Ejemplares similares